ArticleDigital health
Phenotype identification and precise intervention for multimorbidity of rheumatoid arthritis and diabetes mellitus using interpretable machine learning.
Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Rheumatoid arthritis (RA) and diabetes mellitus (DM) frequently coexist, yet the heterogeneity of RA-DM multimorbidity remains unclear. This study aims to develop an interpretable machine learning framework to reveal the phenotypic subgroups of RA-DM multimorbidity, providing a potential direction for precision public health interventions. Methods: Utilizing data from the National Health and Nutrition Examination Survey (1999-2018), we developed a Bayesian-optimized eXtreme Gradient Boosting (XGBoost) model to classify RA-DM multimorbidity status and compared with other machine learning models. Shapley Additive Explanations (SHAP) was applied to interpret the optimal model and quantify the contributions of different features. A dual-clustering approach combining Self-Organizing Maps and K-means was used to identify RA-DM phenotypic subgroups with different feature contribution patterns based on SHAP profiles. Results: The optimized XGBoost model achieved the best classification performance, outperforming other models such as K-nearest neighbors, support vector machine and logistic regression. SHAP analysis identified nine key contributing features (homocysteine, age, glucose, etc), and revealed non-linear interactions among the features. The dual-clustering based on SHAP values identified four distinct RA-DM phenotypes-inflammatory, metabolically protective, age-related and non-obese protective-each exhibiting unique clinical and biochemical patterns. Conclusion: This study established an interpretable machine learning framework for identifying distinct phenotypes of RA-DM multimorbidity. These findings provide a data-driven basis for targeted interventions in precision public health, while offering a transferable paradigm for phenotype discovery in other multimorbid conditions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.